Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]
Focus on getting maximum nutritional value from each calorie by choosing mostly whole, minimally processed foods
Why choose Retatrutide
Frohnert BI, Sinaiko AR, Serrot FJ, Foncea RE, Moran A, Ikramuddin S, et al
Adems, se llev a cabo un estudio de fase 3b de 52 semanas (SUSTAIN 11) para estudiar el efecto de la semaglutida en comparacin con la insulina asprtica (en bolo con las tres comidas principales), tanto como complemento de la metformina como de la insulina glargina optimizada (U100)
Na rynku dostpnych jest kilka lekw, ktre zawieraj semaglutyd